- An advisory panel at the U.S. Food and Drug Administration on Wednesday said that a decades-old birth control pill should be sold without a prescription, paving the way for the first over-the-counter contraceptive pill to be approved nationally.
- In a unanimous vote, the FDA advisers supported pharmaceutical manufacturer Perrigo’s request to sell its daily birth control pill, Opill, over the counter.
- The recommendation is non-binding, but if the FDA follows it, then Opill would become the first contraceptive medication to be moved from a prescription-only basis to the store shelves.
Trending
FDA Panel Gives Thumbs Up To Over-The-Counter Abortion Pill
Key FDA Panel Wants It Available Without Prescription
FILE - Boxes of the drug mifepristone sit on a shelf at the West Alabama Women's Center in Tuscaloosa, Ala., March 16, 2022. Vermont's Republican governor Phil Scott signed abortion and gender affirming shield bills into law Wednesday, May 10, 2023, that include protecting access to a medication widely used in abortions even if the U.S. Food and Drug Administration withdraws its approval of the pill, mifepristone. (AP Photo/Allen G. Breed, File)
